Spanish biopharmaceutical company PharmaMar has selected Medidata Solutions' Medidata Clinical Cloud platform to accelerate clinical trials for marine-based oncology drugs. A member of the Zeltia Group and a developer of antitumor drugs ...
Endocyte has chosen the combined solution of Medidata’s electronic data capture (EDC) and clinical data management (CDM) system Medidata Rave along with Medidata CTMS. The cloud based platform will facilitate Endocyte to support its ...
Tags: Endocyte, Medidata trial, cancer, diseases
Medidata Solutions has unveiled Medidata Balance, a randomization and trial supply management (RTSM) technology. The new solution provides the block randomization methodology, to assign newly enrolled patients to a treatment group, in ...
Tags: Medidata Solutions, Medidata balance, RTSM
Mesoblast will implement Medidata Solutions cloud-based platform, Medidata Rave along with Rave Safety Gateway, Rave Targeted SDV and Medidata Coder across its clinical studies. The technologies are expected to support the development of ...
Pharmaceutical Research and Manufacturers of America (PhRMA), and Analysis Group (AG), an economic consulting firm, have selected Medidata Solutions' (MDSO) cost databases for clinical trial analysis. PhRMA and AG are analyzing the costs ...
Tags: PhRMA, Analysis Group, MDSO, CROCAS databases
TKL Research has selected Medidata CTMS clinical trial management system to expand its clinical trial operations. The software-as-a-service allows TKL to identify sites that can enroll the exact patients by measuring actual ...
Tags: clinical trial management system, pharmaceuticals industry
Kaketsuken, also known as the Chemo-Sero-Therapeutic Research Institute, has become the first Japanese pharmaceutical company to use the combined capabilities of the Medidata Balance and Medidata Rave for a Japanese clinical trial. ...